In 2021, the market for the Global Atrial Fibrillation Devices Industry was estimated to be worth US$ 3.2 billion, and by 2032, it is anticipated to be worth US$ 17.9 billion. With a market share of more than 59%, the ablation catheter segment dominates the global market under the product category. Over the forecast period (2022–2032), it …